Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,009 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL

NCT02910063

Conditions
B-cell Non Hodgkin Lymphoma, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Oklahoma City, Oklahoma, United States
  • Research Site Greenville, South Carolina, United States
View all 31 locations
View Trial Details
Completed

Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction

NCT04339712

Conditions
COVID-19, Corona Virus Infection, Coronaviridae Infections, +14 more
Locations
  • 2nd Department of Critical Care Medicine, ATTIKON University Hospital Athens, Haidari, Greece
  • Intensive Care Unit, Ioannina University Hospital Ioannina, Greece
  • Department of Internal Medicine, Patras University Hospital Pátrai, Rion, Greece
  • Department of Internal Medicine, I PAMMAKARISTOS Hospital Athens, Greece
View all 17 locations
View Trial Details
Completed

An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin's Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL)

NCT03289182

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Soon Chun Hyang University Hospital Bucheon Bucheon-si, South Korea
  • Inje University Busan Paik Hospital Busan, South Korea
  • Pusan National University Hospital Busan, South Korea
  • Keimyung University Dongsan Medical Center Daegu, South Korea
View all 25 locations
View Trial Details

Related conditions